FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082422 [Registered on: 17/03/2025] Trial Registered Prospectively
Last Modified On: 16/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [lepa application ]  
Study Design  Single Arm Study 
Public Title of Study   To study Vranashodhan Kesari Lepa In The Management Of Dushta Vrana With Special Reference To Infected Wound 
Scientific Title of Study   A Randomized Clinical Study Of Vranashodhan Kesari Lepa In The Management Of Dushta Vrana With Special Reference To Infected Wound 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rahul Popat Thakare 
Designation  PG Scholar 
Affiliation  Vidarbha Ayurved Mahavidyalaya, Amravati. 
Address  OPD No.22,Shalya Tantra Department, Vidarbha Ayurved Mahavidyalaya and Hospital, Dhanvantari Nagar, Amravati.
Amravati
Amravati
MAHARASHTRA
444605
India 
Phone  9960001698  
Fax    
Email  iamrahul22royal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manjusha S Kalmegh 
Designation  Guide and HOD Department of Shalyatantra 
Affiliation  Vidarbha Ayurved Mahavidyalaya, Amravati. 
Address  OPD No.22,Shalya Tantra Department, Vidarbha Ayurved Mahavidyalaya and GNT Hospital, Dhanvantari Nagar, Amravati.
Amravati
Amravati
MAHARASHTRA
444605
India 
Phone  9422155851  
Fax    
Email  manjushakalmegh75@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rahul Popat Thakare 
Designation  PG Scholar 
Affiliation  Vidarbha Ayurved Mahavidyalaya, Amravati. 
Address  OPD No.22,Shalya Tantra Department, Vidarbha Ayurved Mahavidyalaya and GNT Hospital, Dhanvantari Nagar, Amravati.
Amravati
Amravati
MAHARASHTRA
444605
India 
Phone  9960001698  
Fax    
Email  iamrahul22royal@gmail.com  
 
Source of Monetary or Material Support  
Vidarbha Ayurved Mahavidyalaya and Hospital, Dhanvantari Nagar,Amravati,444605,India. 
 
Primary Sponsor  
Name  Vidarbha Ayurved Mahavidyalaya Amravati 
Address  Vidarbha Ayurved Mahavidyalaya and Hospital,Dhanvantari Nagar,Amravati 444605,India. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rahul Popat Thakare  Vidarbha Ayurved Mahavidyalaya,Amravati  OPD No.22,Shalya Tantra Department, Vidarbha Ayurved Mahavidyalaya and Hospital, Dhanvantari Nagar, Amravati. Amravati
Amravati
MAHARASHTRA 
09960001698

iamrahul22royal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
S.H.V.P.M.Vidarbha Ayurved Mahavidyalaya,Amravati  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L089||Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: DUSHTAVRANAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-lepa, लेप (Procedure Reference: Dravyagun vidynan uttarardha yadavji, Procedure details: (Procedure Reference: Dravyagun vidynan uttarardha yadavji, Procedure details: Lepa Application details: Before lepa application wound will be cleaned. On first day at morning, Vranashodhan Kesari Lepa will be applied over wound surface and wound be closed by dressing. Route of Administration: Topical Duration:45days Dose: as per wound size (at morning) Dressing : once a day) (1) Medicine Name: Vranashodhan Kesri Lepa , Reference: Chakradatta 44/28 , Route: Topical, Dosage Form: Lepa Churna, Dose: 10(g), Frequency: od, Duration: 45 Days Delete)
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1 patients who will give consent for the study
2 patients with all types of Dushtavrana with maximum history of more than or equal to 2 weeks and less than 1 month
3 patients having clinical features of nija and agantuja vrana ie foul smell pus discharge pain burning sensation and edema (eg neglected wound post op infected wound body extrimities cellulities wound) will be selected for study 
 
ExclusionCriteria 
Details  1.The patient who has underlying bony lesions
2. Patients with Malignant Ulcer.
3. Tuberculous Ulcer.
4. Lepromatous Ulcer.
5. HIV, HbSAg positive patients.
6. Bleeding disorders.
7. Gangrenous wound.
8.Diabetic Wound will not be selected.
9.Animal bite injuries.
10) Delicate organ injury 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Complete remission from dushtavrana (infected wound) .

Marked improvement in dushtavrana (infected wound)

Mild improvement in dushtavrana (infected wound). 
0th day
4th day
7th day
10th day
14th day
17th day
21th day
24th day 
 
Secondary Outcome  
Outcome  TimePoints 
Remission from all kind of wound
Normal granulation tissue achieved  
31th day
35th day
38th day
42th day
45th day 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A Randomised clinical trial will be conducted to study the Vranashodhan Kesri Lepa in the management of Dushta vrana with special reference to Wound.

Trial will be conducted in our Institute and its periphery. Total 70 patients diagnosed with infected wound will be selected in the group.

One group will be advised to use Vranashodhan Kesri Lepa on the wound surface.

The study will be done for 60 days. Results will be derived. Data analysis will be done by using appropriate statistical test. Primary outcomes will be to study the Vranashodhan Kesri Lepa and complete, moderate and mild remission of infected wound in patients.
 
Close